Thierry Lambert
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry.
Journal: Research and practice in thrombosis and haemostasis
Published: January 31, 2025
Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry.
Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 23, 2024
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS).
Journal: Research and practice in thrombosis and haemostasis
Published: March 08, 2024
Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada.
Journal: Research and practice in thrombosis and haemostasis
Published: June 05, 2023
Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 03, 2023
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 13, 2021
In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model.
Journal: Hepatology (Baltimore, Md.)
Published: May 20, 2021
AsnB is responsible for peptidoglycan precursor amidation in Clostridium difficile in the presence of vancomycin.
Journal: Microbiology (Reading, England)
Published: May 08, 2020
Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study.
Journal: Thrombosis and haemostasis
Published: March 19, 2020
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 18, 2019
Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution.
Journal: Antimicrobial agents and chemotherapy
Published: September 27, 2019
Last Updated: 09/26/2026